The majority of observations suggest that p53 is required for anti-tumor activities of TAMs, as p53 is generally associated with the proinflammatory macrophage phenotype, increased levels of IL-6 and IL-12, and enhanced phagocytic activity [52,74,203,204,207]. The gene discussed is TP53; the disease is neoplasm.